This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cogent Biosciences, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Tanna Bettendorf: Innovator in FGFR Inhibition
Introduction
Tanna Bettendorf is a prominent inventor based in Boulder, CO. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for FGFR inhibition. Her innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Tanna Bettendorf holds 1 patent for her invention titled "Compounds for FGFR inhibition." This patent describes a compound with a specific structure, including stereoisomers, salts, or tautomers. The pharmaceutical composition comprising these compounds and their applications in treating diseases are also detailed in her patent.
Career Highlights
Tanna is currently associated with Cogent Biosciences, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in the pharmaceutical industry.
Collaborations
Throughout her career, Tanna has collaborated with notable professionals, including Jay Bradford Fell and John E Robinson. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Tanna Bettendorf's contributions to FGFR inhibition exemplify her dedication to advancing medical science. Her innovative spirit and collaborative efforts position her as a key figure in the pharmaceutical field.